20
Dr. Reddy's Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their significant offerings is Rivastigmine hydrogen tartrate, Process – I, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-248 - Rev 00
This Chemical Type CEP, issued on December 09, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2630 associated with this CEP further emphasizes